BE827926A - Antibiotique - Google Patents

Antibiotique

Info

Publication number
BE827926A
BE827926A BE155402A BE155402A BE827926A BE 827926 A BE827926 A BE 827926A BE 155402 A BE155402 A BE 155402A BE 155402 A BE155402 A BE 155402A BE 827926 A BE827926 A BE 827926A
Authority
BE
Belgium
Prior art keywords
antibiotic
Prior art date
Application number
BE155402A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE827926A publication Critical patent/BE827926A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/188—Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D503/00—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
BE155402A 1974-04-20 1975-04-14 Antibiotique BE827926A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB17410/74A GB1508977A (en) 1974-04-20 1974-04-20 Beta-lactam antibiotic from streptomyces clavuligerus

Publications (1)

Publication Number Publication Date
BE827926A true BE827926A (fr) 1975-10-14

Family

ID=10094711

Family Applications (1)

Application Number Title Priority Date Filing Date
BE155402A BE827926A (fr) 1974-04-20 1975-04-14 Antibiotique

Country Status (6)

Country Link
AT (1) AT352270B (fr)
BE (1) BE827926A (fr)
CS (1) CS231157B2 (fr)
GB (1) GB1508977A (fr)
SU (1) SU648117A3 (fr)
ZA (1) ZA752492B (fr)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2646004A1 (de) * 1975-10-13 1977-04-21 Beecham Group Ltd Clavulansaeureaether, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
US4098897A (en) 1975-04-14 1978-07-04 Beecham Group Limited Anti bacterial agents
US4571392A (en) * 1977-05-19 1986-02-18 Beecham Group Limited 6-Substituted derivatives of clavulanic acid
US5734048A (en) * 1995-05-16 1998-03-31 Chong Kun Dang Corp. Process for manufacturing clavulanic acid salt
EP2589663A1 (fr) 2011-11-04 2013-05-08 LEK Pharmaceuticals d.d. Procédé de production d'acide clavulanique

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0008525A3 (fr) * 1978-08-25 1980-05-28 Beecham Group Plc Compositions pharmaceutiques et procédé pour leur préparation
IL58461A0 (en) * 1978-10-27 1980-01-31 Beecham Group Ltd Intramammary compositions comprising a clavulanic acid salt
US4454069A (en) * 1979-08-24 1984-06-12 Beecham Group Limited Clavulanic acid salts and their preparation from the tertiary butyl amine salt
EP0026044B1 (fr) * 1979-08-24 1983-06-08 Beecham Group Plc Sel amine de l'acide clavulanique, sa préparation et son utilisation
AU600655B2 (en) * 1984-10-27 1990-08-23 Beecham Group Plc Preparation of clavulanic acid and its salts and esters
US5750685A (en) * 1987-01-29 1998-05-12 Smithkline Beecham, P.L.C. Process for preparing potassium clavulanate in rossette form
NZ223316A (en) * 1987-01-29 1989-10-27 Beecham Group Plc Crystalline potassium clavulanate and pharmaceutical compositions
US5288861A (en) * 1987-01-29 1994-02-22 Beecham Group Plc Potassium clavulanate in rosette form
AT400033B (de) 1992-03-10 1995-09-25 Biochemie Gmbh Neues verfahren zur isolierung und reinigung von clavulansäure und zur herstellung von pharmakologisch verträglichen salzen derselben
AT399155B (de) * 1992-03-26 1995-03-27 Lek Tovarna Farmacevtskih Neue alkylendiammonium-diclavulanat-derivate, verfahren zu deren herstellung sowie deren verwendung
SI9300296B (sl) 1992-06-11 1998-06-30 Smithkline Beecham P.L.C. Postopek in intermedianti za pripravo klavulanske kisline
SI9200139A (en) * 1992-07-08 1994-03-31 Lek Tovarna Farmacevtskih New inclusion complex of clavulanic acid with hydrophylyc and hydropholyc beta-cyclodextrin derivates for production of them
KR100200239B1 (ko) * 1992-10-21 1999-06-15 김충환 클라불란산 칼륨염의 제조방법
DE4318916A1 (de) * 1993-06-07 1994-12-08 Bayer Ag Cyclobutylazole
GB9401969D0 (en) * 1994-02-02 1994-03-30 Smithkline Beecham Plc Process
SI9400107A (en) * 1994-03-02 1995-10-31 Lek Tovarna Farmacevtskih New process of the isolation of clavulanic acid and its pharmaceutical salts from fermented broth of streptomyces sp.p 6621 ferm p 2804.
GB9408117D0 (en) 1994-04-23 1994-06-15 Smithkline Beecham Corp Pharmaceutical formulations
GB9424950D0 (en) * 1994-12-10 1995-02-08 Smithkline Beecham Plc Novel process
PL321871A1 (en) * 1995-02-25 1997-12-22 Spurcourt Ltd Clavulanic salts and compositions containing them as well as method of obtaining such salts
SI9500074A (en) * 1995-03-10 1996-10-31 Lek Tovarna Farmacevtskih Process for preparation of alkani salts of clavulanic acid.
SI9500265A1 (en) 1995-08-28 1997-02-28 Lek Tovarna Farmacevtskih Process for purification of the aqueous fermented broth filtrate of streptomyces sp. p 6621 ferm p 2804 by ultrafiltration
ES2101658B1 (es) * 1995-11-23 1998-03-01 Antibioticos Sa Nuevo procedimiento de produccion de acido clavulanico y sus sales.
US6414142B1 (en) * 1996-06-13 2002-07-02 Smithkline Beecham Corporation Process for preparing potassium clavulanate
GB9616536D0 (en) 1996-08-06 1996-09-25 Quadrant Holdings Cambridge Co-amoxiclav dosage form
AT404728B (de) * 1996-11-27 1999-02-25 Biochemie Gmbh Verfahren zur herstellung von clavulansäure-aminsalzen
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
US6294199B1 (en) 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
US7250176B1 (en) 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
US6426342B2 (en) 1999-08-16 2002-07-30 Revaax Pharmaceuticals, Llc Use of β-lactamase inhibitors as neuroprotectants
NZ517663A (en) 1999-08-16 2006-02-24 Revaax Pharmaceuticals Llc Neurotherapeutic clavulanate composition and method
US6489319B2 (en) 1999-08-16 2002-12-03 Revaax Pharmaceuticals, Llc Neurotherapeutic use of carboxypeptidase inhibitors
CA2408853C (fr) 2000-05-13 2012-01-10 Smithkline Beecham P.L.C. Procede
US6756057B2 (en) 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
WO2002030392A2 (fr) 2000-10-12 2002-04-18 Beecham Pharmaceuticals (Pte) Limited Nouvelle formulation
ES2357595B1 (es) * 2009-10-02 2012-03-15 Instituto Mediterr�?Neo Para El Avance De La Biotecnolog�?A Y La Investigación Sanitaria (Fundación Imabis) Composición de �?cido clavul�?nico y uso para el diagnóstico en alergolog�?a.
TR200909787A2 (tr) 2009-12-25 2011-07-21 Bi̇lgi̇ç Mahmut Üçüncü kuşak bir sefalosporin ve klavulanik asit içeren farmasötik formülasyonlar.
TR201000687A1 (tr) 2010-01-29 2011-08-22 Bi̇lgi̇ç Mahmut Aktif madde olarak sefiksim ve klavulanik asit içeren efervesan formülasyonlar
TR201000688A2 (tr) 2010-01-29 2011-08-22 B�Lg�� Mahmut Aktif madde olarak sefaklor ve klavulanik asit içeren efervesan formülasyonlar.
TR201000686A1 (tr) 2010-01-29 2011-08-22 B�Lg�� Mahmut Bakteriyel enfeksiyonların tedavisinde suda çözünebilir sefdinir ve klavulanik asit formülasyonları.@
CN115433701B (zh) * 2022-11-08 2023-03-17 南京农业大学 一株变形杆菌及其菌剂和在降解头孢类抗生素中的应用

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4098897A (en) 1975-04-14 1978-07-04 Beecham Group Limited Anti bacterial agents
US4428937A (en) 1975-04-14 1984-01-31 Beecham Group Limited Antibacterial agents
DE2646004A1 (de) * 1975-10-13 1977-04-21 Beecham Group Ltd Clavulansaeureaether, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
US4571392A (en) * 1977-05-19 1986-02-18 Beecham Group Limited 6-Substituted derivatives of clavulanic acid
US5734048A (en) * 1995-05-16 1998-03-31 Chong Kun Dang Corp. Process for manufacturing clavulanic acid salt
EP2589663A1 (fr) 2011-11-04 2013-05-08 LEK Pharmaceuticals d.d. Procédé de production d'acide clavulanique
WO2013064687A2 (fr) 2011-11-04 2013-05-10 Lek Pharmaceuticals D.D. Procédé de production d'acide clavulanique

Also Published As

Publication number Publication date
ATA298575A (de) 1979-02-15
ZA752492B (en) 1976-06-30
SU648117A3 (ru) 1979-02-15
GB1508977A (en) 1978-04-26
AT352270B (de) 1979-09-10
CS272175A2 (en) 1984-02-13
CS231157B2 (en) 1984-10-15

Similar Documents

Publication Publication Date Title
BE827926A (fr) Antibiotique
FR2281687A1 (fr) Copieur-telecopieur
SE7513570L (sv) Antibiotikum
SE7514033L (sv) Nytt antibiotiskt komplex
BE829199A (fr) Composition antibiotique
FI55396C (fi) Manoevreringsanordning
JPS5111866A (ja) Hichakuzainosetsugohoho
JPS5111011A (ja) Fukajiboryoaruminiumugokinpanno seizohoho
JPS5111488A (ja) Hitsuparishikensochi
JPS5112113A (ja) Kasetsutoteepurekooda
JPS511049A (ja) Sohokoshingokenshutsukairo
BE826873A (fr) Alkylsulfonylphenoxypropanolamines
BE827408A (fr) Ureidocephalosporines antibiotiques
SE7510815L (sv) Halvledardon
JPS5131191A (ja) Suireikaitentaiinkyoku x senkan
JPS5110247A (ja) Doatsugatasurasutojikuke
JPS5110510A (ja) Chodendojikifujosharyo
ATA727274A (de) Webschaft
JPS5113850A (ja) Chakushokuhorienkabiniruno netsuanteikasoseibutsu
JPS5110765A (ja) Shusekikairobuhin
JPS5114174A (ja) Kiekisetsushokusochi
JPS5111548A (ja) Kotaichoonpachensen
JPS5112081A (ja) Ryutaiatsusadosochi
BE826955A (fr) Benzoxazolines
JPS5110819A (ja) Saishokusekimensementobanno yojohoho

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: BEECHAM GROUP LTD

Effective date: 19950414